The document summarizes presentations from startups at a Healthtech Innovation Queensland event. It introduces QHeart Medical, which is developing a device called BioQ CA to treat heart failure by reducing aortic stiffness. GravityFit was presented as developing an exercise system based on 30 years of research into the sensory effect of gravity. The document also summarizes Audeara, which is creating an autonomous ear screening device to address the problem of high rates of ear disease, particularly in remote communities.
Best practices to fund, develop and commercialize evidence-based innovationSharpBrains
In this session we discussed key lessons learned for scientists and start-ups to successfully bring to market evidence-based innovative solutions. We will also present non-dilutive funding opportunities and commercialization resources offered through the US small business research programs. A scientist and inventor turned serial entrepreneur will wrap-up the day sharing insights from his previous venture–funded by the NIMH and sold to McKesson–and his current strategy and vision.
--Chair: Dr. Alison Fenney, Executive Director of the Neurotechnology Industry Organization
--Dr. Margaret Grabb, SBIR/STTR Program Director at the National Institute of Mental Health (NIMH)
--Dr. Rex Jakobovits, Founder of Vivalog Technologies and Experiad
Learn more at sharpbrains.com
Expo Day: Bridge Builders Collaborative, American Academy of Clinical Neurops...SharpBrains
During Expo Day selected Summit Partners and Sponsors showcased their latest initiatives and solutions.
--Charlie Hartwell, Operating Partner at The Bridge Builders Collaborative, delivered an Overview of the Mind Training Space.
--Dr. Bob Bilder, Chief of Medical Psychology & Neuropsychology at UCLA, announced the Disruptive Technology Initiative by the American Academy of Clinical Neuropsychology (AACN).
--Ron Riesenbach, Managing Director of the Canadian Centre for Aging and Brain Health Innovation (CC-ABHI), presented Spark and three other new funding programs.
Learn more at sharpbrains.com
Best practices to fund, develop and commercialize evidence-based innovationSharpBrains
In this session we discussed key lessons learned for scientists and start-ups to successfully bring to market evidence-based innovative solutions. We will also present non-dilutive funding opportunities and commercialization resources offered through the US small business research programs. A scientist and inventor turned serial entrepreneur will wrap-up the day sharing insights from his previous venture–funded by the NIMH and sold to McKesson–and his current strategy and vision.
--Chair: Dr. Alison Fenney, Executive Director of the Neurotechnology Industry Organization
--Dr. Margaret Grabb, SBIR/STTR Program Director at the National Institute of Mental Health (NIMH)
--Dr. Rex Jakobovits, Founder of Vivalog Technologies and Experiad
Learn more at sharpbrains.com
Expo Day: Bridge Builders Collaborative, American Academy of Clinical Neurops...SharpBrains
During Expo Day selected Summit Partners and Sponsors showcased their latest initiatives and solutions.
--Charlie Hartwell, Operating Partner at The Bridge Builders Collaborative, delivered an Overview of the Mind Training Space.
--Dr. Bob Bilder, Chief of Medical Psychology & Neuropsychology at UCLA, announced the Disruptive Technology Initiative by the American Academy of Clinical Neuropsychology (AACN).
--Ron Riesenbach, Managing Director of the Canadian Centre for Aging and Brain Health Innovation (CC-ABHI), presented Spark and three other new funding programs.
Learn more at sharpbrains.com
Harness digital platforms to accelerate R&D and drive proper adoptionSharpBrains
Pioneers in education, medicine and pharma discussed new data-rich approaches to help assess what works and what doesn’t, and for whom, accelerating R&D initiatives and proper adoption.
--Chair: Alvaro Fernandez, CEO & Editor-in-Chief of SharpBrains
--Richard Varn, Director of the Center for Advanced Technology and Neuroscience at Educational Testing Service (ETS)
--Dr. Brian Iacoviello, Director of Scientific Affairs at Click Therapeutics
--Dr. Gahan Pandina, Senior Director, Venture Leader at Janssen Research & Development
--Dr. Sarah Banks, Head of Neuropsychology at the Cleveland Clinic Lou Ruvo Center for Brain Health
Learn more at sharpbrains.com
The external healthcare environment is changing rapidly and providers are under increasing pressure to innovate with increasing speed and efficiency.
Be it experimenting with new care delivery models to improve care coordination, redesigning workflows to enhance efficiency, or developing new products that improve clinical outcomes, hospitals and their service lines are looking for effective ways to harness the creative power of physicians and employees to solve problems that matter. However, few organizations innovate in an orderly, reliable way.
Great ideas remain captive in the heads of physicians and employees and one-off attempts to spur innovation through “hack-a-thons” and “pitch days” prove disappointing. As an academic medical center and a world leader in orthopedics, Hospital for Special Surgery has a long history of results-oriented innovation.
In this webinar, we will share:
– HSS’ systematic approach for driving innovation
– strategies for generating new insights and developing novel solutions
– processes for piloting and testing new ideas
– guiding principles for creating a culture of innovation
– advice on how to build your very own innovation infrastructure
About the Speaker:
Mark Angelo is Vice President, Innovation & Business Development for Hospital for Special Surgery. Mark joined HSS in 2009 and has held various senior management positions at the Hospital across operations, strategy and business development. As Vice President, Innovation & Business Development, Mark is responsible for advancing hospital strategic priorities related to quality and efficiency, innovation, growth and diversification. One of his key responsibilities includes leading the Operational Excellence program, a hospital-wide initiative that leverages industrial engineering principles to maximize quality and efficiency. Mark also leads the HSS Innovation Center whose mission is to support the development and commercialization of early-stage technologies and solutions.
Prior to joining HSS, Mark worked as a management consultant for Monitor Group where he specialized in operations strategy and organizational design. Mark holds a Bachelor of Applied Science in Biomedical Engineering from the University of Toronto and a Master of Business Administration from Harvard Business School.
Expo Day: MindMaze, SharpBrains, Watson Centre for Brain HealthSharpBrains
During Expo Day selected Summit Partners and Sponsors showcased their latest initiatives and solutions.
--Dr. Daniel Perez-Marcos, Senior Scientist at MindMaze, presented the MindMotion platform–a series of medical-grade virtual reality solutions for neurorehabilitation.
--Alvaro Fernandez. SharpBrains‘ CEO & Editor-in-Chief discussed The State of Brain Health Innovation.
--Mark Watson, Co-Director of the Watson Centre for Brain Health, explored latest research and programs for cognitive rehabilitation.
Learn more at sharpbrains.com
Nhs innovation accelerator understanding how and why the nhs adopts innovationHugh Risebrow
Thanks Nael Clarke for highlighting Wessex AHSN report on adoption of innovation in the NHS. Innovation is difficult in any organisation, but why is it so much harder in the NHS than in say Apple, Amazon or most private businesses: My views:
1. Organisational success. In private b2c companies, success results from attracting and retaining customers through delivering innovative services which meet their needs better than competition. In the NHS, success is much more about achieving arbitrary political targets, and patients have limited choice.
2. Organisational incentives. Many innovative companies set divisional objectives around the proportion of income from new products.
3. Individual and team incentives. In successful b2c businesses, financial and career recognition/ promotion rewards are often linked to innovation. There is recognition that innovation may need a few reiterations to succeed. In the NHS, few get fired for preserving the status quo, but many lose out of they innovate and it fails first time round, and there are no individual or team incentives.
Many in the NHS seek to innovate in order to deliver better care at a lower cost. They are often faced with organisational resistance or at least inertia, and excessive bureaucracy.
Lesson 101 in management s that you get the behaviours that you incentivise. (How) should the NHS change the incentives? Is there scope for more NHS owned 'spin-outs' which allow private sector type financial incentives for staff, and greater freedom from NHS bureaucracy and governance?
Taking cognitive/ emotional assessments and therapies to scaleSharpBrains
Three digital health entrepreneurs–who have collectively raised over $75 million in venture capital in the last 18 months– and an investor discussed their respective visions and approaches to revolutionize brain and mental health in areas such as ADHD, substance abuse, and general brain fitness.
--Chair: Rita Carter, Science writer and BBC Contributor
--Edward Kliphuis, Investment Director at Merck Ventures
--Dr. Eddie Martucci, CEO of Akili Interactive Labs
--Dr. Corey McCann, CEO of Pear Therapeutics
Learn more at sharpbrains.com
Consumerism, Innovation and Best Practices to Thrive in the Future of HealthJustin Barnes
May 1, 2019 University of Toronto, Dalla Lana School of Public Health, The Institute of Health Policy, Management and Evaluation (IHPME) Keynote speaker Justin Barnes, a health innovation strategist and co-founder of Health Innovation Think Tank, will provide yet another integral perspective focused on the ways in which we can scale up and implement evidence-based changes in health care technology on a global scale. Having testified before Congress on more than twenty occasions delivering statements on virtual care, alternative payment methods, consumerism, connected health and the globalization of healthcare, Justin offers thought leadership for the university, the healthcare community as well as other key stakeholders.
Consumer Driven Health – IHPME Research Day
Looks to the Future of Health Care
The trend towards consumer driven health, whether it be mobile apps, wearable devices, or easy access to electronic health records, is changing the landscape of our health care system and the way we think about care.
Think Tank VI Overview & Best PracticesJustin Barnes
We started the Health Innovation Think Tank 3 years ago to form a highly collaborative environment that creates and shares best practices as well as strategies to successfully navigate the future of healthcare
We cover 3 primary themes in this session: Care Strategy, Innovation and Leadership. Today is about education, collaboration as well as best practice & strategy sharing. Everyone here is unscripted and on the frontlines of healthcare.
The MaRS EXCITE (Excellence in Clinical Innovation and Technology Evaluation) program helps innovators collaborate with the health system to accelerate the pace of adoption of innovative health technologies in Ontario and global markets.
At the end of the program, innovators will have feedback and data on the effectiveness, competitiveness, and economic value of their medical devices or health technology. With this data, innovators are better equipped to approach payers in multiple markets for reimbursement.
Prioritized by senior executives from the health system, only technologies that have true breakthrough potential are allowed into the program.
For more information visit www.marsdd.com.
Think Tank V Key Takeaways & Best PracticesJustin Barnes
Care Strategy, Care Collaboration, Innovation, Industry Disruptors & Social Determinants of Health best practices directly and unscripted from thought leaders on the front lines of healthcare
Aare Kasemets 'How to cut the developmental curve of Western European countri...Aare Kasemets
...The case of Estonian governance reforms 1992-2015: better regulation and control of corruption measures."
Slides of PADOS project* kick-off conference in Helsinki. *Participatory Democracy, Open Governance & Efficient eGovernment Services (PADOS) – Capacity Building Support to Eastern Partnership Countries* by Finland & Estonia (*Armenia, Azerbaidzan, Belarus, Georgia, Moldova and Ukraine). Kick-off conference 1-2.4.2015 in Helsinki
Harness digital platforms to accelerate R&D and drive proper adoptionSharpBrains
Pioneers in education, medicine and pharma discussed new data-rich approaches to help assess what works and what doesn’t, and for whom, accelerating R&D initiatives and proper adoption.
--Chair: Alvaro Fernandez, CEO & Editor-in-Chief of SharpBrains
--Richard Varn, Director of the Center for Advanced Technology and Neuroscience at Educational Testing Service (ETS)
--Dr. Brian Iacoviello, Director of Scientific Affairs at Click Therapeutics
--Dr. Gahan Pandina, Senior Director, Venture Leader at Janssen Research & Development
--Dr. Sarah Banks, Head of Neuropsychology at the Cleveland Clinic Lou Ruvo Center for Brain Health
Learn more at sharpbrains.com
The external healthcare environment is changing rapidly and providers are under increasing pressure to innovate with increasing speed and efficiency.
Be it experimenting with new care delivery models to improve care coordination, redesigning workflows to enhance efficiency, or developing new products that improve clinical outcomes, hospitals and their service lines are looking for effective ways to harness the creative power of physicians and employees to solve problems that matter. However, few organizations innovate in an orderly, reliable way.
Great ideas remain captive in the heads of physicians and employees and one-off attempts to spur innovation through “hack-a-thons” and “pitch days” prove disappointing. As an academic medical center and a world leader in orthopedics, Hospital for Special Surgery has a long history of results-oriented innovation.
In this webinar, we will share:
– HSS’ systematic approach for driving innovation
– strategies for generating new insights and developing novel solutions
– processes for piloting and testing new ideas
– guiding principles for creating a culture of innovation
– advice on how to build your very own innovation infrastructure
About the Speaker:
Mark Angelo is Vice President, Innovation & Business Development for Hospital for Special Surgery. Mark joined HSS in 2009 and has held various senior management positions at the Hospital across operations, strategy and business development. As Vice President, Innovation & Business Development, Mark is responsible for advancing hospital strategic priorities related to quality and efficiency, innovation, growth and diversification. One of his key responsibilities includes leading the Operational Excellence program, a hospital-wide initiative that leverages industrial engineering principles to maximize quality and efficiency. Mark also leads the HSS Innovation Center whose mission is to support the development and commercialization of early-stage technologies and solutions.
Prior to joining HSS, Mark worked as a management consultant for Monitor Group where he specialized in operations strategy and organizational design. Mark holds a Bachelor of Applied Science in Biomedical Engineering from the University of Toronto and a Master of Business Administration from Harvard Business School.
Expo Day: MindMaze, SharpBrains, Watson Centre for Brain HealthSharpBrains
During Expo Day selected Summit Partners and Sponsors showcased their latest initiatives and solutions.
--Dr. Daniel Perez-Marcos, Senior Scientist at MindMaze, presented the MindMotion platform–a series of medical-grade virtual reality solutions for neurorehabilitation.
--Alvaro Fernandez. SharpBrains‘ CEO & Editor-in-Chief discussed The State of Brain Health Innovation.
--Mark Watson, Co-Director of the Watson Centre for Brain Health, explored latest research and programs for cognitive rehabilitation.
Learn more at sharpbrains.com
Nhs innovation accelerator understanding how and why the nhs adopts innovationHugh Risebrow
Thanks Nael Clarke for highlighting Wessex AHSN report on adoption of innovation in the NHS. Innovation is difficult in any organisation, but why is it so much harder in the NHS than in say Apple, Amazon or most private businesses: My views:
1. Organisational success. In private b2c companies, success results from attracting and retaining customers through delivering innovative services which meet their needs better than competition. In the NHS, success is much more about achieving arbitrary political targets, and patients have limited choice.
2. Organisational incentives. Many innovative companies set divisional objectives around the proportion of income from new products.
3. Individual and team incentives. In successful b2c businesses, financial and career recognition/ promotion rewards are often linked to innovation. There is recognition that innovation may need a few reiterations to succeed. In the NHS, few get fired for preserving the status quo, but many lose out of they innovate and it fails first time round, and there are no individual or team incentives.
Many in the NHS seek to innovate in order to deliver better care at a lower cost. They are often faced with organisational resistance or at least inertia, and excessive bureaucracy.
Lesson 101 in management s that you get the behaviours that you incentivise. (How) should the NHS change the incentives? Is there scope for more NHS owned 'spin-outs' which allow private sector type financial incentives for staff, and greater freedom from NHS bureaucracy and governance?
Taking cognitive/ emotional assessments and therapies to scaleSharpBrains
Three digital health entrepreneurs–who have collectively raised over $75 million in venture capital in the last 18 months– and an investor discussed their respective visions and approaches to revolutionize brain and mental health in areas such as ADHD, substance abuse, and general brain fitness.
--Chair: Rita Carter, Science writer and BBC Contributor
--Edward Kliphuis, Investment Director at Merck Ventures
--Dr. Eddie Martucci, CEO of Akili Interactive Labs
--Dr. Corey McCann, CEO of Pear Therapeutics
Learn more at sharpbrains.com
Consumerism, Innovation and Best Practices to Thrive in the Future of HealthJustin Barnes
May 1, 2019 University of Toronto, Dalla Lana School of Public Health, The Institute of Health Policy, Management and Evaluation (IHPME) Keynote speaker Justin Barnes, a health innovation strategist and co-founder of Health Innovation Think Tank, will provide yet another integral perspective focused on the ways in which we can scale up and implement evidence-based changes in health care technology on a global scale. Having testified before Congress on more than twenty occasions delivering statements on virtual care, alternative payment methods, consumerism, connected health and the globalization of healthcare, Justin offers thought leadership for the university, the healthcare community as well as other key stakeholders.
Consumer Driven Health – IHPME Research Day
Looks to the Future of Health Care
The trend towards consumer driven health, whether it be mobile apps, wearable devices, or easy access to electronic health records, is changing the landscape of our health care system and the way we think about care.
Think Tank VI Overview & Best PracticesJustin Barnes
We started the Health Innovation Think Tank 3 years ago to form a highly collaborative environment that creates and shares best practices as well as strategies to successfully navigate the future of healthcare
We cover 3 primary themes in this session: Care Strategy, Innovation and Leadership. Today is about education, collaboration as well as best practice & strategy sharing. Everyone here is unscripted and on the frontlines of healthcare.
The MaRS EXCITE (Excellence in Clinical Innovation and Technology Evaluation) program helps innovators collaborate with the health system to accelerate the pace of adoption of innovative health technologies in Ontario and global markets.
At the end of the program, innovators will have feedback and data on the effectiveness, competitiveness, and economic value of their medical devices or health technology. With this data, innovators are better equipped to approach payers in multiple markets for reimbursement.
Prioritized by senior executives from the health system, only technologies that have true breakthrough potential are allowed into the program.
For more information visit www.marsdd.com.
Think Tank V Key Takeaways & Best PracticesJustin Barnes
Care Strategy, Care Collaboration, Innovation, Industry Disruptors & Social Determinants of Health best practices directly and unscripted from thought leaders on the front lines of healthcare
Aare Kasemets 'How to cut the developmental curve of Western European countri...Aare Kasemets
...The case of Estonian governance reforms 1992-2015: better regulation and control of corruption measures."
Slides of PADOS project* kick-off conference in Helsinki. *Participatory Democracy, Open Governance & Efficient eGovernment Services (PADOS) – Capacity Building Support to Eastern Partnership Countries* by Finland & Estonia (*Armenia, Azerbaidzan, Belarus, Georgia, Moldova and Ukraine). Kick-off conference 1-2.4.2015 in Helsinki
Getting started at the national level from demonstration to spreadProqualis
Apresentação de Derek Freeley durante o SIMPÓSIO EINSTEIN-IHI: Implantação e Disseminação de Programas de Segurança do Paciente aconteceu de 3 a 5 de novembro de 2013, em São Paulo - Brasil.
Derek Freeley é Vice Presidente Executivo do Institute for Healthcare Improvement (IHI), tem responsabilidades executivas por conduzir estratégias do IHI em cinco áreas de atuação: desenvolvimento de habilidade; cuidado centrado no paciente e família; segurança do paciente; qualidade; custo e valor; e grande foco em populações. Antes de integrar a equipe do IHI em 2013, foi diretor geral de saúde e assistência social e diretor executivo do National Health Service (NHS) na Escócia.
EIT Health was established in 2015, as a ‘knowledge and innovation community’ (KIC) of the European Institute of Innovation and Technology (EIT). The EIT is made up of various KICs who each focus on a different sector, or area, of innovation – in our case, that is health and aging. The idea behind the EIT KICs is that innovation flourishes best when the right people are brought together to share expertise. The so called ‘knowledge triangle’, is the principle that when experts from business, research and education work together as one, an optimal environment for innovation is created.
https://eithealth.eu/
Presentation by Clare Woods, Business Development Manager for MedTech, NIHR at Excel in Health: developing your innovation for business on Tuesday 12 March 2019 at the Innovation Centre, Daresbury.
PPPI - the involvement of patients or people in the design and development o...ipposi
Dr Jean Saunders, University of Limerick, and IPPOSI Board Member (Science) presents at the 5th World Congress on Advanced Clinical Trials and Clinical Research on public and patient involvement in clinical trials.
Asia HealthTech Investments by Julien de Salaberry (30 June 2015)KickstartPH
Kickstart Ventures' 2nd HealthTech Forum featured Julien de Salaberry, a globally-recognised expert on healthcare and technology.
Julien, the Chief Innovation Officer and Founder of The Propell Group (based in Singapore), talked about healthcare trends in Southeast Asia and how “frugal innovation" can be done in healthcare delivery.
And yeah, if you've got an interesting healthtech startup, message us at info@kickstart.ph. #startupPH
By: Fiona Fitzgerald, GE Healthcare Canada
At Sherbrooke International Life Sciences Summit - 2nd edition | September 28/29/30 2015
www.sils-sherbrooke.com
III Edició "The British Experience in Technologies for Health". Hospital de Sant Pau, Barcelona. 9 de novembre de 2011. Esdeveniment organitzat per la Fundació TICSalut i el Departament de Comerç i Inversions del Consolat General Britànic a Barcelona, UK Trade & Investment, per posar en contacte oportunitats i coneixements entre el Regne Unit i Catalunya.
Similar to Healthtech Innovation QLD 9 Dec14 event (20)
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Best Ayurvedic medicine for Gas and IndigestionSwastikAyurveda
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Healthtech Innovation QLD 9 Dec14 event
1. Healthtech Innovation Queensland
9th December 2014 MeetUp at
TRI
Translational Research Institute
Showcasing 5 excellent
Health and Medical Start-ups
2. Thankyou for supporting
Healthtech Innovation Queensland
We are here to:
Build a dynamic healthcare innovation
community in Queensland
Foster, attract, retain and globally
commercialise healthtech start-ups
Make a difference to individual & community
health & wellbeing
3. Entrepreneurs Transforming
Healthcare
Startup Health USA
Check out this excellent video to see
our vision for this group
https://www.youtube.com/watch?feature=player_detailpage&v=oLjtIYEQM_c
4. Healthcare Innovation Investment
Around the World is on the Move
In the USA alone
• $5 billion invested in digital health alone the
1st 3 Qtrs 2014
• Funding to nearly double year-over-year
5. Healthcare Innovation in Australia
• Australia’s health tech start-up scene is active
• Funding & resourcing remains a major issue for start-ups
• No dedicated healthcare incubators and accelerators
• We are planning to start Healthtech weekend workshops
in the New Year with a focus on investment readiness and
growth strategies
6. What Can We Do to Make Queensland a
Healthcare Innovation Hub?
We MUST
• Get researchers, innovators, government,
corporates and investors collaborating,
supporting and investing in the sector
• Build national & international networks and
strategic alliances
7. Welcome to the following
Healthtech Queensland Start-ups
Panel
Dr Carrie Hillyard, Scientist, VC, Deputy Chairman of the Mater Medical
Research Institute , Chairman FizzioFit, Fitgenes and more
Dr Clarence Tan, Asia Pacific Ambassador Singularity University , Angel
Investor, CEO and Chairman, Bond Wireless , Adjunct Professor Bond /Griffith
Universities
Bernie Woodcroft, Director iLab
8. QHeart Medical
Innovative Heart Therapy
Peter W Walsh, Ph.D.
CEO & President
QHeart Medical
peter@qheartmedical.com
www.qheartmedical.com Copyright QHeart Medical 2014
9. The Problem: Heart Failure
• Heart failure (HF): 5.7M Americans, 8M EU, 350K AU.
• Incidence increasing ~10% pa.
• 70% of HF patients are hypertensive.
• 26% are in Class III HF and highly unserved.
• 1.8 million patients US & EU in Class III HF unserved.
(hypertension without severe aortic disease) (~47K AU).
• DRH: 17M Americans, min. 10% unserved.
• A large emerging unserved market.
10. Secondary Heart Pump
is the expansion and contraction of the aorta which reduces
heart load and drives coronary blood flow.
Aorta
Left Coronary Artery
• Aortic stiffness 77% higher in hypertensive HF suffers
(Hundley et al, 2001).
11. The Solution: BioQ CA
passive recoil extra aortic balloon counterpulsation
• Gas filled extra aortic
balloon.
• Gas compresses and expands
in response to systolic and
diastolic aortic load (low
fatigue).
• Subcutaneous inflation port
allows adjustment on routine
visits to cardiologist.
12. BioQ CA Features
• Novel extra-aortic balloon (EAB) counterpulsation device.
• Reduces aortic stiffness and restores 2nd heart pump (increase
aortic expansion and contraction).
• Fully implanted, self-powered, no pump or control system, no
leads, non blood contacting, minimally invasive.
• Proof of concept in animal studies:
– Reduced pulse (27%) & mean pressure (10%), &
significant increase in left coronary artery blood flow
(up 39%).
– Chronic safety study data over 2 months (non-GLP).
• Failure mode safe, cost effective.
• No other product that directly restores aortic biomechanics,
restoring blood pressure to normal levels.
13. Current Activities
• Ethics approved at Indian Hospital for first-in-man pilot
clinical study (for study in Q1 2015).
– funded by an Australian-India Council Grant via
UNSW.
• Prep work for pilot clinical study at Princess Alexandra
Hospital (PAH) Brisbane (Q1-Q2 2015).
– funded by Qld Visiting Medical Officer Trust Grant via
PAH.
• Capital raising prep work and offer Q1 2015.
– Product refinement and clinical trials.
– Exit: trade sale or partnership with large medtech
player.
• Exploring partnership with Chinese group.
14. Venture Summary
• Innovative technology serving multiple unmet market need.
• Attractive proof of concept animal data.
• Issued and pending patent protection.
• High potential for disruptive technology (breakthrough).
• Expected reduction in clinical & medication costs.
• Expected improvement in quality of life.
• Competitive, simple, economical product.
• Experienced team and advisors.
• “one of the most exciting growth markets in medical
devices,” Sean Salmon, VP & GM Medtronic CV.
17. GravityFit Therapeutic Exercise System
Revolutionary new science
based on 30 years research and
innovation by the founder of Core Stability
Addresses musculoskeletal conditions
prevalent in modern life
Focusses on sensory effect of Gravity –
developed during research with European
Space Agency
Incorporates
Exercise Tools
Education and Training
Online measurement, methodology and
exercise progressions
18. Current Status
• Q1 2014 - Products manufactured, courses developed, website built
• Q2 2014 – Soft launch commenced with worldwide interest
• Q2/Q3 2014 – Product sales, courses delivered, advocates in Aust, UK,
Courses
Individual Product
sales (wholesale)
Kit
Product sales
(retail)
Europe, US, Asia
• Viable business established through ‘word of mouth’ marketing
• Numerous opportunities identified to expand – funding needed to
capitalise on growth opportunities specifically through extra resources
19. Business Growth Opportunities
•Online Content Distribution
•Online courses for musculo-skeletal experts/ fitness industry
•Level 2 accreditation courses
•Schools/ Aged Care Programs
• International conferences
•US courses in March
•Speaking/trade slots – COPA, Italy
HEALTH SECTOR
•Pharmacy Wellness program
•Whole Body Vibration
•Corporate Health/Wellness
Help me feel better
FITNESS/WELLNESS
•Golf
•Online Golf Drills - mobile application (Golf Aust)
•NZ Golf, UK Golf & US Golf
•Rotation sports
•Tennis, Baseball, Cricket, Swimming
•Ballet and other performance disciplines
Help me live better
SPORT
Help me perform better
20. The Future
GravityGroup – GravityHealth, GravityFX, GravityFit
International Testing &Training Centres
Second/ Third Gen products (sensors and mobile apps)
Smart Performance Suit (wearable technology)
Further innovations based on new science
21. Challenges
Managing quickly growing global interest
• Growth occurring without infrastructure set up/resources
• Staying focussed on key goals – but still remaining flexible!
• Choosing partners and not committing too early
Having a complete system rather than a simple product offering
• Building a brand rather than launching a product
• Perception – more complicated to adopt system
• Education & training required for system
Broad scope - application across markets
• Remaining focussed on low fruit and not grabbing at everything
• Delaying new innovation/ products with applications in other markets
22. We hear you
Introducing
Chris Jeffry
World leader in
screening and diagnosis
of ear disease.
23. PROBLEM
Ear disease is a big problem
WHO warns health crisis if >4%
QLD communities up to 80%
The Australian health system is
desperate to address this issue better
Current system is cumbersome,
expensive and slow
25. SOLUTION
Direct to user, bypasses complicated system
Autonomous screening without specialists
Enables parallel screening
Eliminates wait times (>1 month instant)
26. Rural
and
Remote
Automated
Diagnostics
General
Practice
Hospitals
MARKETS
Deadly Ears, Deadly Kids,
Deadly Communities
-> $4.1mil per year
-> 4% of Qld market
Australia
1,300,000 referrals per year
->$26mil per year
Positive hospital balance
$10.27mil-to-15mil
Queensland
260,000 referrals per year
$20 per Audeara test
Gross Income: $5.2mil per year
Positive hospital balance of
$2mil-to-3mil
27. Competitors
Tympany (Ototronix) industry leader in RnD
focused on automated assessment.
Standard audiometric providers
Gordon N.Stowe, Guymark, P.C. Werth and
SLE
AVANT A2D+ - focused on computer
assisted audiology
Sound scouts and Windows audiometer –
patient focused screening
28. Chris Jeffery
(MBBS, B. Eng,
GCELead)
Robotics and
small scale
electronics
(Australian
Defence Force)
Callum
Potts
(MBBS, BSc,
GCELead)
Former founding
director of
luxury apparel
start-up
TEAM
Logan
Gardner
(MBBS, B. Eng)
Signal
processing and
software design
(Boeing)
29. Execution
Bench-Top
Prototype
IP Secured
TGA/FDA
Trial
Metro
Hospital
Partnership
National
Partnership
Rural Health
OHS Industry
International
Roll Out
Public
Screening
30. MARKETS
Currently Tested
260,000/year in Qld (1.2mil
Australia)
Current Target
Known Problem, No Access
Rural, remote, ATSI
communities
OH&S on mining/industrial
sites (interest exists)
Access, Needs Screening
Older population
School-based children
No Access, Needs Screening
General population –
hearing ability is not a static
quality
37. health, productivity, profitability
The impact of unhealthy
workers on the economy
US
$150 billion
productivity
lost
Australia
$17 billion
absenteeism
Source: Gallup Healthways Well-being Index, 2011 37
38. health, productivity, profitability
The problem for CFO
increasing costs
where am I being impacted the most?
what preventive programs work?
how do I know when something changes?
how do I measure the ROI?
39. health, productivity, profitability
Our Solution
Employment
Medical
Health
Management
Injury
Management
Exit Medical
Data
Aggregation
Hire to retire
Target quantified
health impacts
Tailor to meet need
Proactive & specific
Quantify ROI
40. health, productivity, profitability
The opportunity
• 600 US Customers
• 65 Australian Customers
• TTM Revenue > $38m
2014
2018
• Proven business model
• 17 Australian Customers
• TTM Growth >100%
• Retention > 95%
Investment
Bootstrap, No Debt
• Scale in US
• Develop predictive capability
41. health, productivity, profitability
Our challenges
• Accelerate revenue growth in Australia
• Land first Customer in US
• Build Team
• Investment to establish & expand in US
42. health, productivity, profitability
health, productivity, profitability
a preventive maintenance platform for the
most important asset
Nick Binns
0409 471151
44. • 54 hours to build a startup
• Brings together people with different skillsets to build
innovations and develop .
a commercial case around
them.
• Facilitated and structured, supported by Mentors
• Pitch ideas for new startup companies, form teams
around those ideas, validate them and work to develop
a prototype.
• Pitch presentation by Sunday evening
• 100,000+ participants, in excess 400 cities worldwide
45. • We need mentors.
• 2 hours slot on Sat or Sun
.
• Varied expertise
• We need marketing channel suggestions for
participants
• Email - Bernie.Woodcroft@ilab.com.au
46. Going Forward!
We NEED your input to make this forum work
Please provide some feed back
Any Volunteers!
47. Thankyou to Our Sponsors
A progressive, multidisciplinary firm with a commitment to supporting technology &
fast growth companies with global ambitions, particularly in the health tech space.
R& D Tax Incentives and Export Marketing Development Grants
Bridging loans for R&D tax incentive recipients
Digital media design and production, marketing & communications
49. For more information about
‘Healthtech Innovation Queensland’
Please contact the organizers
Greg Beaver greg.beaver@fitgenes.com 0413585026
Tracey Porst tracey.porst@fitgenes.com 0409302694
John Driscoll john.driscoll@altezzapartners.com.au 0413967398